pM oral sEH epoxide hydrolase inhibitor
completed Ph. I HV study + in animal health
epoxide-opening transition-state mimic
J. Med. Chem., Feb. 7, 2021
EicOsis Human Health Inc., Davis, CA
EC5026
8. The EicOsis oral soluble epoxide hydrolase (sEH) inhibitor, EC5026, is a compound currently intended as a non-opioid analgesic and anti-inflammatory agent. It recently completed a Ph. I study…